Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics

FOLD POWR Grades

• Growth is the dimension where FOLD ranks best; there it ranks ahead of 85.52% of US stocks.
• FOLD's strongest trending metric is Quality; it's been moving up over the last 52 weeks.
• FOLD's current lowest rank is in the Momentum metric (where it is better than 8.84% of US stocks).

FOLD Stock Summary

• Of note is the ratio of Amicus Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 19.84% of US stocks have a lower such ratio.
• With a price/sales ratio of 10.75, Amicus Therapeutics Inc has a higher such ratio than 83.49% of stocks in our set.
• Amicus Therapeutics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -7.86%, greater than the shareholder yield of 25.27% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Amicus Therapeutics Inc, a group of peers worth examining would be DYAI, EYEN, ALBO, CDAK, and PXLW.
• FOLD's SEC filings can be seen here. And to visit Amicus Therapeutics Inc's official web site, go to www.amicusrx.com.

FOLD Valuation Summary

• FOLD's price/sales ratio is 10.8; this is 4.85% lower than that of the median Healthcare stock.
• Over the past 174 months, FOLD's price/sales ratio has gone NA NA.
• FOLD's price/earnings ratio has moved down 7.1 over the prior 174 months.

Below are key valuation metrics over time for FOLD.

FOLD Growth Metrics

• Its 5 year cash and equivalents growth rate is now at 77.35%.
• Its 2 year cash and equivalents growth rate is now at 7.79%.
• Its 3 year net cashflow from operations growth rate is now at -165.09%.

Over the past 15 months, FOLD's revenue has gone up $73,107,000.

The table below shows FOLD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	281.823	-200.107	-252.301
2021-03-31	266.763	-197.702	-253.568
2020-12-31	260.886	-233.29	-276.852
2020-09-30	245.608	-241.3	-295.18
2020-06-30	226.939	-254.845	-292.978
2020-03-31	208.716	-279.812	-325.037

FOLD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• FOLD has a Quality Grade of C, ranking ahead of 63.39% of graded US stocks.
• FOLD's asset turnover comes in at 0.333 -- ranking 138th of 680 Pharmaceutical Products stocks.
• RDUS, CLVS, and NSTG are the stocks whose asset turnover ratios are most correlated with FOLD.

The table below shows FOLD's key quality metrics over time.